The AHA today responded to a Department of Health and Human Services request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances, including opioids, while preventing diversion and abuse. The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 calls for HHS’ Office of the Assistant Secretary for Planning and Evaluation to submit a report to Congress on the issue. Among other actions, AHA recommends providing additional support for medical education, training and guidance for non-opioid pain management as well as for state drug courts, which offer justice-involved individuals with substance use disorders the opportunity to enter treatment programs.

Related News Articles

Headline
The AHA, along with the American Medical Association, today urged the Centers for Medicare & Medicaid Services to delay by at least one year the Jan. 1,…
Chairperson's File
COVID-19 has been at the forefront for health care professionals, and for everyone, this year. And it looks like it will remain that way for some time. However…
Headline
The House of Representatives last night voted 233-188 along party lines to pass a $1.5 trillion bill (H.R. 2) introduced by Democratic leaders to rebuild…
Perspective
As James Madison wrote in the First Amendment of our Bill of Rights, we have the right to “petition the government for a redress of grievances.” We also have…
Headline
More than 350 hospital and health system leaders from across the country this afternoon participated in an AHA Virtual Advocacy Day to urge senators to include…
Perspective
Expanding access to telehealth services to provide much more patient-centered, convenient care. Creating additional health care workforce capacity and avoiding…